News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,592 Results
Type
Article (2839)
Company Profile (40)
Press Release (43713)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (15804)
Career Advice (85)
Deals (2296)
Drug Delivery (9)
Drug Development (4601)
Employer Resources (11)
FDA (1004)
Job Trends (978)
News (23364)
Policy (1370)
Tag
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (176)
Allergies (7)
Alliances (3905)
ALS (4)
Alzheimer's disease (54)
Antibody-drug conjugate (ADC) (18)
Approvals (1011)
Artificial intelligence (13)
Autoimmune disease (3)
Automation (1)
Bankruptcy (14)
Best Places to Work (684)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (21)
Cancer (153)
Cardiovascular disease (10)
Career advice (72)
Career pathing (1)
CAR-T (16)
Cell therapy (51)
Cervical cancer (2)
Clinical research (3613)
Collaboration (98)
Compensation (52)
COVID-19 (186)
CRISPR (7)
C-suite (32)
Cystic fibrosis (2)
Data (152)
Denatured (3)
Depression (6)
Diabetes (11)
Diagnostics (521)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (16)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (5033)
Editorial (3)
Employer branding (1)
Employer resources (9)
Events (7146)
Executive appointments (102)
FDA (1079)
Featured Employer (4)
Funding (87)
Gene editing (14)
Generative AI (1)
Gene therapy (23)
GLP-1 (61)
Government (179)
Healthcare (885)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (191)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (9)
IPO (1061)
IRA (7)
Job creations (306)
Job search strategy (68)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (268)
Liver cancer (7)
Lung cancer (16)
Lymphoma (4)
Management (4)
Manufacturing (21)
MASH (4)
Medical device (902)
Medtech (902)
Mergers & acquisitions (1308)
Metabolic disorders (35)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (108)
NextGen: Class of 2025 (415)
Non-profit (181)
Northern California (403)
Now hiring (4)
Obesity (16)
Opinion (16)
Ovarian cancer (10)
Pain (12)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (25)
Patient recruitment (7)
Peanut (1)
People (6075)
Pharmaceutical (5)
Phase I (1486)
Phase II (1772)
Phase III (985)
Pipeline (90)
Policy (12)
Postmarket research (75)
Preclinical (652)
Press Release (3)
Prostate cancer (4)
Psychedelics (2)
Radiopharmaceuticals (14)
Rare diseases (25)
Real estate (445)
Recruiting (6)
Regulatory (1070)
Reports (6)
Research institute (168)
Resumes & cover letters (10)
RNA editing (1)
Schizophrenia (14)
Series A (29)
Series B (8)
Service/supplier (2)
Sickle cell disease (1)
Southern California (383)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (511)
Stomach cancer (1)
Supply chain (5)
The Weekly (1)
United States (2077)
Vaccines (29)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (35)
Last 7 days (101)
Last 30 days (289)
Last 365 days (2924)
2025 (952)
2024 (3020)
2023 (3342)
2022 (4379)
2021 (4671)
2020 (4029)
2019 (2632)
2018 (2010)
2017 (2217)
2016 (2097)
2015 (2372)
2014 (1779)
2013 (1540)
2012 (1821)
2011 (1697)
2010 (1473)
Location
Africa (51)
Alabama (1)
Alaska (1)
Arizona (17)
Asia (2279)
Australia (396)
California (930)
Canada (155)
China (42)
Colorado (24)
Connecticut (10)
Delaware (4)
Europe (4794)
Florida (54)
Georgia (7)
Idaho (3)
Illinois (24)
India (1)
Indiana (33)
Japan (9)
Kansas (15)
Maine (2)
Maryland (32)
Massachusetts (356)
Michigan (29)
Minnesota (53)
Missouri (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (91)
New York (86)
North Carolina (96)
Northern California (403)
Ohio (28)
Oklahoma (2)
Oregon (6)
Pennsylvania (58)
Rhode Island (3)
South America (53)
South Carolina (1)
Southern California (383)
Tennessee (2)
Texas (78)
Utah (2)
Virginia (7)
Washington D.C. (1)
Washington State (55)
Wisconsin (6)
46,592 Results for "pulse biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
April 23, 2025
·
4 min read
Press Releases
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
April 25, 2025
·
1 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 25, 2025
April 28, 2025
·
2 min read
Press Releases
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
March 26, 2025
·
1 min read
Press Releases
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 4, 2025
·
4 min read
Press Releases
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
February 20, 2025
·
1 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Business
Pulse Biosciences Enhances Executive Leadership Team
Pulse Biosciences, Inc., a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, announced enhancements to its executive leadership team to support its next pivotal phase of growth.
May 14, 2024
·
7 min read
Press Releases
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
March 7, 2025
·
1 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
1 of 4,660
Next
